InvestorsHub Logo
icon url

BeingReal

02/02/17 2:31 PM

#89579 RE: Reyeton #89575

Is that a common or regular occurrence; for a company to buy another company's compound for just one indication while leaving the other indications on the table for the company (Anavex) to explore?